The European Medicines Agency recommends the usage of the Pfizer–BioNTech COVID-19 vaccine as a booster dose for teenagers over the age of 12 years and also approves the use of the Moderna COVID-19 vaccine for children between the ages of 6 and 11 years. 2022-02-24
The French Haute Autorité de santé approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years. 2021-12-20
Sri Lanka begins administering the COVID-19 vaccine for children between the ages of 12 and 19 years old with special health needs and disabilities using the Pfizer-BioNTech vaccine. 2021-09-24
The Ministry of Health issues an emergency use authorization for the Pfizer–BioNTech COVID-19 vaccine, becoming the fourth vaccine to be approved for use in Vietnam. 2021-06-12
The Philippines receives its first shipment of 193,050 doses of the Pfizer–BioNTech COVID-19 vaccine distributed through the COVAX initiative. 2021-05-10
The Palestinian National Authority receives 61,440 doses of the COVID-19 vaccine. 37,440 of the doses are the Pfizer-BioNTech vaccine and the other 24,000 doses are the Oxford-AstraZeneca vaccine. 2021-03-17
Malaysia receives its first shipment of 312,390 doses of the Pfizer–BioNTech vaccine. This allows the starting date of the vaccination campaign to be brought forward to February 24. 2021-02-21
Hong Kong approves the BioNTech vaccine for emergency use in the city. 2021-01-25
Prime Minister Benjamin Netanyahu becomes the first Israeli to get a second dose of Pfizer's tozinameran vaccine as the country begins administering second doses of the vaccine to the public. 2021-01-9